Gemcitabine and docetaxel as a second-line treatment in advanced soft tissue sarcomas

  • Hend Ahmed El-Hadaad, Hanan Ahmed Wahba
  • Clinical Oncology and Cancer Research, September 2011, Springer Science + Business Media
  • DOI: 10.1007/s11805-011-0571-y

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1007/s11805-011-0571-y